Foghorn Therapeutics furnishes investor presentation; no specific material updates disclosed in exhibit

Foghorn Therapeutics Inc.

Investor presentation title: 'Unique biology, Precision therapeutics, Broad impact' — no additional content provided.
No financial results, pipeline updates, or guidance changes are included in this filing.
The filing does not contain any material new information beyond the existence of the presentation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.